1. A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers. Issue 4 (14th October 2019) Authors: Qureshi, Irfan; Lovegren, Meghan; Wirtz, Victoria; Larouche, Richard; Tanguay, Mario; Anderson, Matt S.; Hartmann, Sonja; Coric, Vlad; Berman, Robert M. Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 4(2020) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. (19th May 2020) Authors: Mullin, Kathleen; Kudrow, David; Croop, Robert; Lovegren, Meghan; Conway, Charles M.; Coric, Vladimir; Lipton, Richard B. Journal: Neurology Issue: Volume 94:Number 20(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine. Issue 8 (16th August 2020) Authors: Berman, Gary; Croop, Robert; Kudrow, David; Halverson, Philip; Lovegren, Meghan; Thiry, Alexandra C.; Conway, Charles M.; Coric, Vladimir; Lipton, Richard B. Journal: Headache Issue: Volume 60:Issue 8(2020) Page Start: 1734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial. Issue 3 (March 2023) Authors: Lipton, Richard B; Croop, Robert; Stock, David A; Madonia, Jennifer; Forshaw, Micaela; Lovegren, Meghan; Mosher, Linda; Coric, Vladimir; Goadsby, Peter J Journal: Lancet neurology Issue: Volume 22:Issue 3(2023) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗